Latest News

 Filter by Provider

Taiwan Semiconductor’s Arizona expansion is accelerating as surging AI chip demand drives profit and revenue growth.

Mình vừa có dịp mua và sử dụng Bosch GSB 185-LI nên viết lại một chút trải nghiệm thực tế cho anh em nào đang tìm máy khoan pin Bosch. Mình vốn quen dùng m

Roper Technologies (NASDAQ:ROP) is pursuing a strategy centered on long-term free-cash-flow-per-share growth, portfolio collaboration and acquisitions of vertical-market software businesses, while increasingly deploying artificial intelligence across its operations and products, Chief Financial Offi

The stock will appeal to investors who are confident in ongoing and long-term trade tensions between the U.S. and China.

Two category leaders are still off their highs, yet continue to report double-digit revenue growth.

The digital real estate platform provider reported a notable insider purchase as its stock eked out a 20% return over the past 12 months.

Whenever RocketLab reports earnings these days, investors and analysts are far more interested in Neutron rocket updates.

RenovoRx (NASDAQ:RNXT) executives and physician speakers discussed the treatment landscape for locally advanced pancreatic cancer, the company’s Trans-Arterial Micro-Perfusion, or TAMP, platform, and commercialization progress for its RenovoCath delivery device during a webinar hosted by JonesTradin

Despite rapid growth, shares of this AI-fueled software company are cheap.

GBPUSD:Exclusively for our readers — get $10 to start trading with no deposit required! Register, complete verification, and enter the promo code TALKMARKE

Lost in the commotion of earnings season, Cloudflare co-founder and CEO Matthew Prince made an extraordinary claim about how internet traffic is changing at an exponential rate, motivating Jon to ask Matt and Tyler to dissect the news and look for investment opportunities. The trio also discusses the latest news in the mining industry as well as Intel’s latest equity sale.

As cybersecurity threats increase, Mastercard is focusing on prevention and defense for its 3.7 billion cardholders.

The opportunity could redefine nuclear power.

Given their solid underlying businesses, reliable cash flows, high yields, and healthy growth prospects, these two high-yield Canadian stocks are ideal for your TFSA.

Receipts keep getting bigger, customer transactions keep slipping -- and the next test comes Tuesday.

One extra withdrawal from your IRA can set off a chain reaction of higher taxes and even surprise Medicare surcharges — for years to come.

Real Brokerage (NASDAQ:REAX) Founder and CEO Tamir Poleg said the company had grown to more than 36,000 agents across the U.S. and Canada, positioning its technology-driven brokerage model for further expansion as it pursues its acquisition of RE/MAX Holdings. Speaking at an Oppenheimer event, Pole

Costco's valuation looks expensive, but its business keeps delivering.

As earnings season winds down, it's time to reflect on lessons from this quarter.

If I had $20,000, here is how I would structure a TFSA portfolio to earn nearly $70 per month of extra passive income.

What happens when the scores we invent to measure success begin quietly reshaping what we value?

VBR's 0.05% expense ratio and $67.8 billion in assets provide broader diversification across 841 holdings versus IJJ's 303 stocks.

Many spousal beneficiaries have been waiting years to cross this threshold.

For many Americans, working a few extra years before retiring seems like an easy solution if their savings aren’t where they want them to be. Personal finance expert Suze Orman says, “I’ll work longer” can be a smart

Tesla's record quarter looks impressive at first glance, but the numbers beneath it raise a much bigger question about the stock's future. Here's what investors need to know.

Taiwan Semiconductor has its fingerprints all over the modern data center.

Avita Medical (NASDAQ:RCEL) reported second-quarter 2026 revenue of $21.7 million, up 13% sequentially from $19.3 million in the first quarter and 18% from $18.4 million a year earlier, as the wound-care company cited growth across its product portfolio and in U.S. and international markets. Presid

The memory maker's earnings keep setting records, and its guidance points to another one. The stock sits about 23% below its high anyway.

Rose Nicole Dominique Reich Sapire exercised stock options and withheld shares to cover tax obligations, retaining 15,246 direct shares and 65,520 options, per her latest Form 4.

AI hardware is becoming harder to manufacture, creating a critical opportunity few investors understand. See which companies could capture the upside and which risks could disrupt the thesis.

જેને: જેની ચિંતા હોય.રહેઠાણ એ કોઈ વૈભવી વસ્તુ નથી - તે એક મૂળભૂત અધિકાર છેઇઝરાયલમાં હજારો અપંગ લોકોને દર મહિને એક અશક્ય વાસ્તવિકતાનો સામનો કરવાની ફરજ પડે છ

Google Cloud is Alphabet's fastest-growing division.

There's good news and bad news.

Earnings season continues to give strong results, but that doesn’t mean each stock is rising because of the news.

Dean's liquidation is on the heels of the stock price climbing nearly 65% over the last 12 months.

Avita Medical (NASDAQ:RCEL) expects continued sequential revenue growth and aims to reach cash flow breakeven in the fourth quarter of 2025, President and CEO Cary Vance said at the Canaccord 46th Annual Boston Growth Conference. Vance, who has been CEO for about 10 months after previously serving

This filing details a non-discretionary tax withholding tied to stock option exercise.

This filing details a non-discretionary sale executed to cover tax withholding from the exercise of vested options.

AeroVironment stock is facing a major test as top Wall Street analysts remain divided about its future and bottoming signs emerge

Analog Devices will publish its financial results later this week, with the options market predicting some modest moves.

They are fairly risky, but their potential upside is massive.

Every three months, I go through an exercise that apparently strikes a large portion of the investing public as hopelessly old fashioned. I look at what successful investors are actually buying. I know. Crazy

The chipmaker's valuation is far higher than those of its peers.

Rani Therapeutics (NASDAQ:RANI) outlined its strategy to expand the use of its RaniPill oral biologic-delivery platform through a mix of technology partnerships, selectively licensed product programs and investments in manufacturing capacity. Chief Executive Officer Talat Imran described the clinic

A 64-year-old man learned the hard way that decades of experience don’t guarantee job security when an employer changes how work gets done. After his company introduced new software, he reportedly refused to learn it,

US corporate AI budgets show extreme disparities, with top 1% spending $7,400 per employee per month vs $11.95 for median firm.

At: pwy bynnag y mae'n ymwneud ag ef.Nid moethusrwydd yw tai — mae'n hawl sylfaenolMae miloedd o bobl ag anableddau yn Israel yn cael eu gorfodi i ddelio â

Nvidia and Meta are attacking artificial intelligence from opposite ends. Discover where each moat is strongest, what could weaken it, and why this battle may produce two winners.

The DRAM ETF has formed the rare inverted head-and-shoulders pattern as memory stocks like Micron and SK Hynix rebounds

You pay a price for those extra years of benefits.